Biomarkers: Troponin testing--risk stratification to stratified medicine.
Publication
, Journal Article
Newby, LK; Ohman, EM
Published in: Nat Rev Cardiol
November 2015
Among patients with diabetes mellitus and ischaemic heart disease, high-sensitivity testing effectively identified 39.3% of patients with elevated troponin levels who were at high 5-year risk of cardiovascular death, myocardial infarction, or stroke. Compared with optimal medical therapy, revascularization did not reduce ischaemic events among patients with elevated troponin levels.
Duke Scholars
Published In
Nat Rev Cardiol
DOI
EISSN
1759-5010
Publication Date
November 2015
Volume
12
Issue
11
Start / End Page
625 / 626
Location
England
Related Subject Headings
- Sensitivity and Specificity
- Risk Assessment
- Myocardial Revascularization
- Myocardial Ischemia
- Humans
- Diabetes Mellitus, Type 2
- Cardiovascular System & Hematology
- Biomarkers
Citation
APA
Chicago
ICMJE
MLA
NLM
Newby, L. K., & Ohman, E. M. (2015). Biomarkers: Troponin testing--risk stratification to stratified medicine. Nat Rev Cardiol, 12(11), 625–626. https://doi.org/10.1038/nrcardio.2015.157
Newby, L Kristin, and E Magnus Ohman. “Biomarkers: Troponin testing--risk stratification to stratified medicine.” Nat Rev Cardiol 12, no. 11 (November 2015): 625–26. https://doi.org/10.1038/nrcardio.2015.157.
Newby LK, Ohman EM. Biomarkers: Troponin testing--risk stratification to stratified medicine. Nat Rev Cardiol. 2015 Nov;12(11):625–6.
Newby, L. Kristin, and E. Magnus Ohman. “Biomarkers: Troponin testing--risk stratification to stratified medicine.” Nat Rev Cardiol, vol. 12, no. 11, Nov. 2015, pp. 625–26. Pubmed, doi:10.1038/nrcardio.2015.157.
Newby LK, Ohman EM. Biomarkers: Troponin testing--risk stratification to stratified medicine. Nat Rev Cardiol. 2015 Nov;12(11):625–626.
Published In
Nat Rev Cardiol
DOI
EISSN
1759-5010
Publication Date
November 2015
Volume
12
Issue
11
Start / End Page
625 / 626
Location
England
Related Subject Headings
- Sensitivity and Specificity
- Risk Assessment
- Myocardial Revascularization
- Myocardial Ischemia
- Humans
- Diabetes Mellitus, Type 2
- Cardiovascular System & Hematology
- Biomarkers